StockNasdaqGSIDXX
Idexx Laboratories
$676.04
+15.04 (+2.28%)today
Valuation & earnings
- P/E ratio
- 45.56
- Forward P/E
- 40.04
- EPS (ttm)
- $14.84
- Forward EPS
- $16.88
- Price/book
- 28.5
- PEG ratio
- 3.14
- Dividend yield
- 0%
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 4.7B
- Revenue growth
- 9.9%
- Profit margin
- 25.36%
- Return on equity
- 68.93%
- Total cash
- 197.5M
- Total debt
- 973M
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 3.41 | 3.47 | +1.74% |
| Dec 31, 2025 | 2.94 | 3.08 | +4.85% |
| Jun 30, 2026 | 3.93 | 4.27 | +8.54% |
| Sep 30, 2026 | 3.71 | 4.01 | +7.98% |
Next earnings date: Feb 1, 2027
Analyst view
Consensus ratingBuy14 analysts
Strong buy 4Buy 5Hold 4Sell 1
12-month price targetsImplied upside: +6.08%
470
717.17
810
LowCurrent priceHigh
Related products
How visible is Idexx Laboratories in AI search?
We ask AI search engines about Idexx Laboratories and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Idexx Laboratories yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.